PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:11 AM ET

Sponsor Check › Person

AK
No photo found yet (own website and image search run after this page is viewed)

Adam Koppel

Named as an officer, director or promoter on SEC Form D filings · MA, CA · Apr 14, 2009 → Jul 24, 2024

14deals (issuers)
$14.48Breported sold
837investors
43Form D filings
2009–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:01 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Adam Koppel is listed as an executive officer and director on 43 SEC Form D filings by 14 issuers between Apr 2009 and Jul 2024. Largest by amount reported sold: BROOKSIDE CAPITAL PARTNERS FUND LP (Boston, MA — pooled investment fund — 2010–2014; $8.91B reported sold to 380 investors), BROOKSIDE CAYMAN LTD (Boston, MA — pooled investment fund — 2010–2014; $2.71B reported sold to 166 investors), Brookside II Cayman Ltd (Boston, MA — pooled investment fund — 2009–2014; $1.12B reported sold to 106 investors), Brookside Capital Partners Fund II, L.P. (Boston, MA — pooled investment fund — 2009–2014; $975.5M reported sold to 80 investors), BROOKSIDE CAYMAN PA LTD (Boston, MA — pooled investment fund — 2010–2014; $389.6M reported sold to 16 investors) and 9 more (all listed below).

What this means That is a lot of deals — 14 separate companies raised money with this person listed as executive officer and director, over about 15 years. Across those companies the filings report $14.48B sold in total.

Listed alongside DENNIS G. GOLDSTEIN (28 shared filings), Dewey J. Awad (28 shared filings), JOHN MICHAEL TOUSSAINT (28 shared filings), Mark C. Moore (28 shared filings), PETER WILLIAM RIEHL (28 shared filings) and 77 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Adam. Each name links to their own page.

The issuers belong to 4 sponsor groups: Bain (13 issuers, $16.61B reported sold, 2009–2025), Bain (4 issuers, $0 reported sold, 2016–2024), Bc Life Sciences (2 issuers, $0 reported sold, 2016–2021) and Solid (3 issuers, $68.7M reported sold, 2014–2022).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 43 public filings for Adam Koppel and found 11 differences, 1 worth asking the sponsor about: 5 people are no longer listed on a later amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Adam Koppel has not run yet — it is joining a line of 48,714 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:01 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Adam Koppel..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:01 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Adam Koppel — 1 worth asking about (compared 43 filings on Oct 24, 2026)

Note · Nov 16, 2018 – Dec 3, 2018

Form D filed 17 days after the first sale — ViaCyte Inc.

The filing says the first sale was Nov 16, 2018. The Form D was filed Dec 3, 2018 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Mar 20, 2020 – Apr 2, 2020

No amendment in the last 12 months on an offering that may still be open — ViaCyte Inc. (latest filing Apr 2, 2020)

The latest filing for this offering is dated Apr 2, 2020 (first sale Mar 20, 2020). It reports $32,645,780 sold of $36,018,634 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Nov 16, 2018 – Dec 3, 2018

No amendment in the last 12 months on an offering that may still be open — ViaCyte Inc. (latest filing Dec 3, 2018)

The latest filing for this offering is dated Dec 3, 2018 (first sale Nov 16, 2018). It reports $35,833,603 sold of $90,021,103 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Worth asking · Feb 26, 2014 – Feb 25, 2015

5 people are no longer listed on a later amendment

Adam Koppel is no longer listed on the Feb 25, 2015 amendment — Brookside II Cayman Ltd · Adam Koppel is no longer listed on the Feb 25, 2015 amendment — Brookside Capital Partners Fund II, L.P. · Adam Koppel is no longer listed on the Feb 25, 2015 amendment — BROOKSIDE CAYMAN PA LTD · Adam Koppel is no longer listed on the Feb 25, 2015 amendment — BROOKSIDE CAYMAN LTD · Adam Koppel is no longer listed on the Feb 25, 2015 amendment — BROOKSIDE CAPITAL PARTNERS FUND LP

What this means People leave; the issuer lists only current officers, directors and promoters. Ask why and who replaced them.

Sources
Note · Apr 14, 2009 – Feb 24, 2011

Adam Koppel is written 2 different ways on the filings

listed as "Adam Koppel" on 23 filings (from Apr 14, 2009), and "Adam MAX Koppel" on 20 filings (from Feb 24, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Feb 26, 2010 – Feb 25, 2015

Reported net asset value range changed between filings — BROOKSIDE CAYMAN LTD

"Not Applicable" (Feb 26, 2010); then "Decline to Disclose" (Feb 25, 2015).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Sources
Note · Mar 21, 2013 – Jul 14, 2022

Same name, different state: "Adam Koppel" (NJ or NC) is a separate record

This page covers filings where the address state is MA or CA. A separate record, "Adam Koppel" with address state NJ or NC, is listed on 5 filings — most recently by Areteia Therapeutics, Inc. (Feb 21, 2025). Both records have filings in the same period (Mar 21, 2013 to Jul 14, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Dec 21, 2017

Same name, different state: "Adam M. Koppel" (IL) is a separate record

This page covers filings where the address state is MA or CA. A separate record, "Adam M. Koppel" with address state IL, is listed on 1 filing — most recently by Aptinyx Inc. (Dec 21, 2017). Both records have filings in the same period (Dec 21, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Nov 3, 2021 – Dec 30, 2022

Address moved from Boston, MA to Burlington, MA — Cardurion Pharmaceuticals, Inc.

The people listed on the Nov 3, 2021 filing give Boston, MA; on the Dec 30, 2022 filing they give Burlington, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Oct 26, 2020 – Dec 9, 2022

Address moved from Cambridge, MA to Charlestown, MA — Solid Biosciences Inc.

The people listed on the Oct 26, 2020 filing give Cambridge, MA; on the Dec 9, 2022 filing they give Charlestown, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Apr 14, 2009 – Jul 24, 2024

Adam Koppel is listed with 2 different address states: MA, CA

MA on 41 filings (Apr 14, 2009 to Jul 24, 2024); CA on 2 filings (Dec 3, 2018 to Apr 2, 2020).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 19 offerings report sales commissions totalling $4,543,800; 1 reports finder's fees totalling $3,125,000; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jul 24, 2024 D
Cardurion Pharmaceuticals, Inc.
File 021-519629
$0$0$0None listed on this filingEDGAR ↗
Mar 28, 2024 D
Bain Capital Life Sciences Fund IV, L.P.
File 021-508980
$0$0$0BAIN CAPITAL DISTRIBUTORS, LLC BrokerCheck CRD 175456 ↗EDGAR ↗
Jul 14, 2023 D/A
Cardurion Pharmaceuticals, Inc.
File 021-419648
$0$3,125,000$0SVB Leerink LLC BrokerCheck CRD 39011 ↗EDGAR ↗
Dec 30, 2022 D
Cardurion Pharmaceuticals, Inc.
File 021-469288
$0$0$0None listed on this filingEDGAR ↗
Dec 9, 2022 D
Solid Biosciences Inc.
File 021-467084
$0$0$0None listed on this filingEDGAR ↗
Aug 3, 2021 D
Bain Capital Life Sciences Fund III, L.P.
File 021-408531
$0$0$0Bain Capital Distributors, LLC BrokerCheck CRD 175456 ↗EDGAR ↗
Aug 3, 2021 D
BC Life Sciences III Private Investors, L.P.
File 021-408527
$0$0$0Bain Capital Distributors, LLC BrokerCheck CRD 175456 ↗EDGAR ↗
Oct 26, 2020 D
Solid Biosciences Inc.
File 021-378864
$0$0$0None listed on this filingEDGAR ↗
Apr 2, 2020 D
ViaCyte Inc.
File 021-364188
$0$0$0None listed on this filingEDGAR ↗
Jul 31, 2019 D
Solid Biosciences Inc.
File 021-345442
$1,800,000$0$0SVB Leerink LLC BrokerCheck CRD 39011 ↗EDGAR ↗
Apr 9, 2019 D
Bain Capital Life Sciences Fund II, L.P.
File 021-336835
$0$0$0Bain Capital Distributors, LLC BrokerCheck CRD 175456 ↗EDGAR ↗
Dec 3, 2018 D
ViaCyte Inc.
File 021-327013
$2,743,800 (est.)$0$0Raymond James & Associates, Inc. BrokerCheck CRD 705 ↗EDGAR ↗
Dec 16, 2016 D
BC Life Sciences Private Investors, L.P.
File 021-276478
$0$0$0Bain Capital Distributors, LLC BrokerCheck CRD 175456 ↗EDGAR ↗
Nov 22, 2016 D
Bain Capital Life Sciences Fund, L.P.
File 021-274935
$0$0$0Bain Capital Distributors, LLC BrokerCheck CRD 175456 ↗EDGAR ↗
Feb 26, 2014 D/A
Brookside II Cayman Ltd
File 021-130192
$0$0$0None listed on this filingEDGAR ↗
Feb 26, 2014 D/A
Brookside Capital Partners Fund II, L.P.
File 021-130190
$0$0$0None listed on this filingEDGAR ↗
Feb 26, 2014 D/A
BROOKSIDE CAPITAL PARTNERS FUND LP
File 021-42652
$0$0$0None listed on this filingEDGAR ↗
Feb 26, 2014 D/A
BROOKSIDE CAYMAN LTD
File 021-42651
$0$0$0None listed on this filingEDGAR ↗
Feb 26, 2014 D/A
BROOKSIDE CAYMAN PA LTD
File 021-62044
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 14

Every issuer that named Adam Koppel on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Cardurion Pharmaceuticals, Inc.

Burlington, MA · Nov 3, 2021 → Jul 24, 2024 · 4 filings
  • Jul 24, 2024 · D · $260,410,720 sold of $260,410,720 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 14, 2023 · D/A · $128,125,000 sold of $128,125,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 30, 2022 · D · $17,500,000 sold of $17,500,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2021 · D · $46,125,000 sold of $128,125,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $260.4M from 19 investors (100% of the $260.4M target) as of the latest filing. Adam is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

Bain Capital Life Sciences Fund IV, L.P.

Boston, MA · Mar 28, 2024
  • Mar 28, 2024 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Adam is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals · group: Solid

Solid Biosciences Inc.

Charlestown, MA · Jul 31, 2019 → Dec 9, 2022 · 3 filings
  • Dec 9, 2022 · D · $9,200,000 sold of $9,200,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 26, 2020 · D · $39,999,996 sold of $39,999,996 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 31, 2019 · D · $59,977,035 sold of $59,977,035 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60M from 15 investors (100% of the $9.2M target) as of the latest filing. Adam is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bc Life Sciences

BC Life Sciences III Private Investors, L.P.

Boston, MA · Aug 3, 2021
  • Aug 3, 2021 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Adam is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

Bain Capital Life Sciences Fund III, L.P.

Boston, MA · Aug 3, 2021
  • Aug 3, 2021 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Adam is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

ViaCyte Inc.

San Diego, CA · Dec 3, 2018 → Apr 2, 2020 · 2 filings
  • Apr 2, 2020 · D · $32,645,780 sold of $36,018,634 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2018 · D · $35,833,603 sold of $90,021,103 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $53.9M from 55 investors (100% of the $36M target) as of the latest filing. Adam is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

Bain Capital Life Sciences Fund II, L.P.

Boston, MA · Apr 9, 2019
  • Apr 9, 2019 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Adam is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bc Life Sciences

BC Life Sciences Private Investors, L.P.

Boston, MA · Dec 16, 2016
  • Dec 16, 2016 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Adam is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

Bain Capital Life Sciences Fund, L.P.

Boston, MA · Nov 22, 2016
  • Nov 22, 2016 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Adam is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

Brookside II Cayman Ltd

Boston, MA · Apr 14, 2009 → Feb 26, 2014 · 6 filings
  • Feb 26, 2014 · D/A · $1,110,902,969 sold of Indefinite · 102 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2013 · D/A · $1,107,202,969 sold of Indefinite · 102 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2012 · D/A · $1,093,115,597 sold of Indefinite · 100 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 24, 2011 · D/A · $948,583,617 sold of Indefinite · 84 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 26, 2010 · D/A · $746,383,000 sold of Indefinite · 66 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Apr 14, 2009 · D · $166,400,000 sold of Indefinite · 19 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗

Raised $1.12B from 106 investors as of the latest filing. Adam is listed as executive officer on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

Brookside Capital Partners Fund II, L.P.

Boston, MA · Apr 14, 2009 → Feb 26, 2014 · 6 filings
  • Feb 26, 2014 · D/A · $925,633,710 sold of Indefinite · 79 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2013 · D/A · $906,058,710 sold of Indefinite · 77 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2012 · D/A · $892,058,710 sold of Indefinite · 73 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 24, 2011 · D/A · $799,858,710 sold of Indefinite · 67 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 26, 2010 · D/A · $579,900,000 sold of Indefinite · 52 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Apr 14, 2009 · D · $122,050,000 sold of Indefinite · 12 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗

Raised $975.5M from 80 investors as of the latest filing. Adam is listed as executive officer on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

BROOKSIDE CAYMAN PA LTD

Boston, MA · Feb 26, 2010 → Feb 26, 2014 · 5 filings
  • Feb 26, 2014 · D/A · $389,600,000 sold of Indefinite · 16 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2013 · D/A · $389,600,000 sold of Indefinite · 16 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2012 · D/A · $389,600,000 sold of Indefinite · 16 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 24, 2011 · D/A · $244,600,000 sold of Indefinite · 14 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 26, 2010 · D/A · $234,600,000 sold of Indefinite · 14 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗

Raised $389.6M from 16 investors as of the latest filing. Adam is listed as executive officer on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

BROOKSIDE CAYMAN LTD

Boston, MA · Feb 26, 2010 → Feb 26, 2014 · 5 filings
  • Feb 26, 2014 · D/A · $2,702,301,681 sold of Indefinite · 164 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2013 · D/A · $2,697,213,381 sold of Indefinite · 163 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 27, 2012 · D/A · $2,697,213,381 sold of Indefinite · 163 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 24, 2011 · D/A · $2,606,629,252 sold of Indefinite · 159 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗
  • Feb 26, 2010 · D/A · $2,568,679,252 sold of Indefinite · 159 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗

Raised $2.71B from 166 investors as of the latest filing. Adam is listed as executive officer on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bain

BROOKSIDE CAPITAL PARTNERS FUND LP

Boston, MA · Jan 12, 2010 → Feb 26, 2014 · 6 filings
  • Feb 26, 2014 · D/A · $8,880,553,236 sold of Indefinite · 376 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Feb 27, 2013 · D/A · $8,864,602,536 sold of Indefinite · 375 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Feb 27, 2012 · D/A · $8,859,602,536 sold of Indefinite · 374 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Feb 24, 2011 · D/A · $8,585,318,407 sold of Indefinite · 373 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Feb 26, 2010 · D/A · $8,481,928,407 sold of Indefinite · 372 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jan 12, 2010 · D/A · $8,481,928,407 sold of Indefinite · 372 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $8.91B from 380 investors as of the latest filing. Adam is listed as executive officer on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Adam Koppel — NJ, NC, 2 issuers, Mar 21, 2013 → Jul 14, 2022 · no shared issuer
  • Adam M. Koppel — IL, 1 issuer, Dec 21, 2017 → Dec 21, 2017 · no shared issuer

People around Adam 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

Dewey J. Awad

Executive Officer · 28 shared filings (5 issuers) · also on 12 other issuers

Dewey J. Awad is on 17 issuers in total — a repeat sponsor. Their page lists every one.

PR
No photo found yet (own website and image search run after this page is viewed)
Person

PETER WILLIAM RIEHL

Executive Officer · 28 shared filings (5 issuers) · also on 7 other issuers

PETER WILLIAM RIEHL is on 12 issuers in total — a repeat sponsor. Their page lists every one.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

JOHN MICHAEL TOUSSAINT

Executive Officer · 28 shared filings (5 issuers) · also on 8 other issuers

JOHN MICHAEL TOUSSAINT is on 13 issuers in total — a repeat sponsor. Their page lists every one.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mark C. Moore

Executive Officer · 28 shared filings (5 issuers) · also on 6 other issuers

Mark C. Moore is on 11 issuers in total — a repeat sponsor. Their page lists every one.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

DENNIS G. GOLDSTEIN

Executive Officer · 28 shared filings (5 issuers) · also on 2 other issuers

DENNIS G. GOLDSTEIN is on 7 issuers in total — a repeat sponsor. Their page lists every one.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

MATTHEW VINCENT MCPHERRON

Executive Officer · 23 shared filings (5 issuers)

MATTHEW VINCENT MCPHERRON is on 5 issuers in total — a repeat sponsor. Their page lists every one.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

ANAND MORE

Executive Officer · 22 shared filings (5 issuers) · also on 6 other issuers

ANAND MORE is on 11 issuers in total — a repeat sponsor. Their page lists every one.

WP
No photo found yet (own website and image search run after this page is viewed)
Person

WILLIAM EDWARD PAPPENDICK IV

Executive Officer · 20 shared filings (5 issuers) · also on 2 other issuers

WILLIAM EDWARD PAPPENDICK IV is on 7 issuers in total — a repeat sponsor. Their page lists every one.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

GREGORY MOORE

Executive Officer · 15 shared filings (5 issuers) · also on 3 other issuers

GREGORY MOORE is on 8 issuers in total — a repeat sponsor. Their page lists every one.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

MARLENE REYNOLDS

Executive Officer · 13 shared filings (5 issuers) · also on 1 other issuer

MARLENE REYNOLDS is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DF
No photo found yet (own website and image search run after this page is viewed)
Person

DOMENIC JAY FERRANTE

Executive Officer · 13 shared filings (5 issuers) · also on 1 other issuer

DOMENIC JAY FERRANTE is on 6 issuers in total — a repeat sponsor. Their page lists every one.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

PHILLIP CARTER

Executive Officer · 13 shared filings (5 issuers)

PHILLIP CARTER is on 5 issuers in total — a repeat sponsor. Their page lists every one.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

DOUGLAS RUDISCH

Executive Officer · 8 shared filings (5 issuers)

DOUGLAS RUDISCH is on 5 issuers in total — a repeat sponsor. Their page lists every one.

TP
No photo found yet (own website and image search run after this page is viewed)
Person

TED PAPPENDICK

Executive Officer · 8 shared filings (5 issuers)

TED PAPPENDICK is on 5 issuers in total — a repeat sponsor. Their page lists every one.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

SEAN DOHERTY

Executive Officer · 8 shared filings (5 issuers) · also on 27 other issuers

SEAN DOHERTY is on 32 issuers in total — a repeat sponsor. Their page lists every one.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

MICHAEL GOSS

Executive Officer · 8 shared filings (5 issuers) · also on 18 other issuers

MICHAEL GOSS is on 23 issuers in total — a repeat sponsor. Their page lists every one.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

ANAD MORE

Executive Officer · 6 shared filings (4 issuers)

Listed on the same filings as Adam Koppel. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Schwartz

Executive Officer · 6 shared filings (6 issuers) · also on 8 other issuers

Jeffrey Schwartz is on 14 issuers in total — a repeat sponsor. Their page lists every one.

RR
No photo found yet (own website and image search run after this page is viewed)
Person

RANESH RAMANATHAN

Executive Officer · 5 shared filings (5 issuers) · also on 28 other issuers

RANESH RAMANATHAN is on 33 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

DAVIS CLAYSON

Executive Officer · 5 shared filings (5 issuers) · also on 1 other issuer

DAVIS CLAYSON is on 6 issuers in total — a repeat sponsor. Their page lists every one.

FV
No photo found yet (own website and image search run after this page is viewed)
Person

FERNANDO VIGIL

Executive Officer · 5 shared filings (5 issuers) · also on 1 other issuer

FERNANDO VIGIL is on 6 issuers in total — a repeat sponsor. Their page lists every one.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

ED BRAKEMAN

Executive Officer · 5 shared filings (5 issuers)

ED BRAKEMAN is on 5 issuers in total — a repeat sponsor. Their page lists every one.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

SOYOUN SONG

Executive Officer · 5 shared filings (5 issuers)

SOYOUN SONG is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Mendelsohn

Executive Officer, Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Adam Koppel. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jeb Keiper

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Adam Koppel. Their page shows their other deals.

PL
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Lawrence

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Adam Koppel. Their page shows their other deals.

ND
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Downing

Director · 4 shared filings (1 issuer)

Listed on the same filings as Adam Koppel. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

MATT MCPHERRON

Executive Officer · 3 shared filings (2 issuers)

Listed on the same filings as Adam Koppel. Their page shows their other deals.

KN
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Novack

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Adam Koppel. Their page shows their other deals.

KG
No photo found yet (own website and image search run after this page is viewed)
Person

Keith Gottesdiener

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Adam Koppel. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Rajeev Shah

Director · 3 shared filings (1 issuer) · also on 17 other issuers

Rajeev Shah is on 18 issuers in total — a repeat sponsor. Their page lists every one.

IG
No photo found yet (own website and image search run after this page is viewed)
Person

Ilan Ganot

Executive Officer, Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Adam Koppel. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Freed

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Adam Koppel. Their page shows their other deals.

IS
No photo found yet (own website and image search run after this page is viewed)
Person

Ian Smith

Director · 3 shared filings (2 issuers) · also on 6 other issuers

Ian Smith is on 8 issuers in total — a repeat sponsor. Their page lists every one.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Stone

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Adam Koppel. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Carl Morris

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Adam Koppel. Their page shows their other deals.

LS
No photo found yet (own website and image search run after this page is viewed)
Person

Lynne Sullivan

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Adam Koppel. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Huffines

Director · 3 shared filings (1 issuer)

Listed on the same filings as Adam Koppel. Their page shows their other deals.

SN
No photo found yet (own website and image search run after this page is viewed)
Person

Sukumar Nagendran

Director · 3 shared filings (1 issuer) · also on 4 other issuers

Sukumar Nagendran is on 5 issuers in total — a repeat sponsor. Their page lists every one.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Abali Hoilett

Director · 2 shared filings (1 issuer) · also on 99 other issuers

Abali Hoilett is on 100 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Sponsor group

Bain

13 issuers · 103 filings · $16.61B reported sold · 2009–2025

One team, 13 deal companies. Adam Koppel is listed on 5 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Adam Koppel.

Sponsor group

Bain

4 issuers · 4 filings · $0 reported sold · 2016–2024

One team, 4 deal companies. Adam Koppel is listed on 4 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Adam Koppel.

Sponsor group

Bc Life Sciences

2 issuers · 2 filings · $0 reported sold · 2016–2021

One team, 2 deal companies. Adam Koppel is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Adam Koppel.

Sponsor group

Solid

3 issuers · 5 filings · $68.7M reported sold · 2014–2022

One team, 3 deal companies. Adam Koppel is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Adam Koppel.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 14 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Adam Koppel by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 14 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Adam Koppel is listed on: none on file. No website or social profile named in BROOKSIDE CAPITAL PARTNERS FUND LP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #105,645 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Adam Koppel appears on a new Form D, or when a court case or SEC action is matched to them. See plans →